Eileen O'Meara Selected Research

Eileen O'Meara Research Topics

Disease

106	Heart Failure 03/2024 - 08/2004
8	Atrial Fibrillation 03/2024 - 01/2010
7	Heart Arrest (Cardiac Arrest) 11/2021 - 04/2014
6	Iron Deficiencies 01/2024 - 12/2010
6	Cardiomyopathies (Cardiomyopathy) 12/2023 - 12/2019
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2019
5	Left Ventricular Dysfunction 02/2024 - 10/2011
5	Inflammation (Inflammations) 01/2024 - 01/2012
5	Chronic Renal Insufficiency 01/2022 - 12/2010
5	Hyperkalemia 01/2019 - 04/2014
5	Anemia 01/2015 - 12/2004
4	Myocardial Infarction 01/2022 - 12/2007
4	Hypokalemia 01/2019 - 04/2014
3	Fibrosis (Cirrhosis) 01/2023 - 12/2011
3	Stroke (Strokes) 01/2022 - 01/2020
3	Systolic Heart Failure 01/2021 - 11/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2017
2	Frailty 01/2023 - 01/2020
2	Heart Diseases (Heart Disease) 01/2022 - 01/2018
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2020 - 10/2017
2	Hypertension (High Blood Pressure) 12/2019 - 05/2012
2	Death (Near-Death Experience) 11/2017 - 05/2011
1	Dyspnea (Shortness of Breath) 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Cardio-Renal Syndrome 01/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2022
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022
1	Gout 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Ketosis 01/2021
1	Amyloidosis 01/2020
1	Transthyretin-Related Hereditary Amyloidosis 01/2020
1	Pulmonary Hypertension 12/2019

Drug/Important Bio-Agent (IBA)

27	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 12/2011
23	dapagliflozinIBA 12/2023 - 11/2019
18	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 08/2004
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
8	Natriuretic PeptidesIBA 12/2023 - 09/2014
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2013
8	candesartanIBA 12/2019 - 11/2004
7	sacubitril and valsartan sodium hydrate drug combinationIBA 07/2023 - 01/2018
6	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 01/2015
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 01/2015
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2018
5	omecamtiv mecarbilIBA 12/2023 - 11/2020
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2019
5	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2019
5	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 09/2014
5	CreatinineIBA 11/2018 - 12/2010
4	ferric carboxymaltoseIBA 01/2024 - 01/2021
4	SodiumIBA 01/2023 - 01/2020
4	Troponin T (Troponin T1)IBA 01/2022 - 09/2014
4	DiureticsIBA 01/2020 - 12/2013
4	IvabradineIBA 12/2019 - 10/2011
4	Angiotensin Receptor AntagonistsIBA 05/2018 - 11/2004
3	paragonIBA 02/2024 - 01/2018
3	IronIBA 12/2023 - 12/2010
3	Cardiac MyosinsIBA 01/2021 - 11/2020
2	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2022
2	Growth Differentiation Factor 15IBA 01/2023 - 12/2018
2	Ferritins (Ferritin)IBA 01/2022 - 12/2010
2	TroponinIBA 01/2022 - 11/2018
2	Transferrin (beta 2 Transferrin)IBA 01/2022 - 12/2010
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2022 - 12/2010
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2022
2	Irbesartan FDA LinkGeneric 12/2019 - 01/2017
2	Enalapril FDA LinkGeneric 01/2019 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 05/2018 - 02/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2018 - 05/2012
2	PotassiumIBA 05/2018 - 01/2015
2	AnticoagulantsIBA 01/2016 - 05/2012
1	C-Reactive ProteinIBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024
1	CarbohydratesIBA 11/2023
1	AntigensIBA 11/2023
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023
1	Clostridium perfringens epsilon-toxinIBA 01/2022
1	SymportersIBA 01/2022
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	HepcidinsIBA 01/2022
1	Carbon DioxideIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	Collagen Type III (Type III Collagen)IBA 01/2021
1	Prealbumin (Transthyretin)IBA 01/2020
1	tafamidisIBA 01/2020

Therapy/Procedure

35	Therapeutics 03/2024 - 12/2004
5	Transjugular Intrahepatic Portasystemic Shunt 01/2021 - 03/2014
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2012
2	Cardiac Resynchronization Therapy 10/2017 - 12/2011
1	Contraindications 01/2023
1	Patient Readmission 10/2022
1	Polypharmacy 11/2021
1	Surgical Amputation (Amputations) 01/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2019